Paul K. Audhya, the CHIEF MEDICAL OFFICER of $KALV, sold 5,354 shares of the company on 02-23-2026 for an estimated $83,344. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.7% of their shares of this class of stock. Following this trade, they now own 138,983 shares of this class of $KALV stock.
$KALV Insider Trading Activity
$KALV insiders have traded $KALV stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $KALV stock by insiders over the last 6 months:
- BENJAMIN L PALLEIKO (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 8 sales selling 47,748 shares for an estimated $710,643.
- PAUL K. AUDHYA (CHIEF MEDICAL OFFICER) has made 0 purchases and 4 sales selling 14,888 shares for an estimated $216,550.
- CHRISTOPHER YEA (CHIEF DEVELOPMENT OFFICER) has made 0 purchases and 4 sales selling 12,470 shares for an estimated $181,408.
- NICOLE SWEENY (Chief Commercial Officer) has made 0 purchases and 2 sales selling 7,788 shares for an estimated $113,166.
- BRIAN PIEKOS (Chief Financial Officer) has made 0 purchases and 2 sales selling 6,238 shares for an estimated $87,645.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KALV Hedge Fund Activity
We have seen 84 institutional investors add shares of $KALV stock to their portfolio, and 85 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 2,283,766 shares (+inf%) to their portfolio in Q4 2025, for an estimated $36,882,820
- KYNAM CAPITAL MANAGEMENT, LP added 1,204,783 shares (+198.8%) to their portfolio in Q4 2025, for an estimated $19,457,245
- VESTAL POINT CAPITAL, LP added 1,140,000 shares (+152.0%) to their portfolio in Q4 2025, for an estimated $18,411,000
- SILVERARC CAPITAL MANAGEMENT, LLC added 1,063,740 shares (+78.0%) to their portfolio in Q4 2025, for an estimated $17,179,401
- GOLDMAN SACHS GROUP INC removed 964,877 shares (-53.6%) from their portfolio in Q4 2025, for an estimated $15,582,763
- MILLENNIUM MANAGEMENT LLC added 800,443 shares (+38.2%) to their portfolio in Q4 2025, for an estimated $12,927,154
- ARMISTICE CAPITAL, LLC added 800,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $12,919,999
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$KALV Analyst Ratings
Wall Street analysts have issued reports on $KALV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 01/09/2026
- HC Wainwright & Co. issued a "Buy" rating on 01/09/2026
To track analyst ratings and price targets for $KALV, check out Quiver Quantitative's $KALV forecast page.
$KALV Price Targets
Multiple analysts have issued price targets for $KALV recently. We have seen 4 analysts offer price targets for $KALV in the last 6 months, with a median target of $31.5.
Here are some recent targets:
- Serge Belanger from Needham set a target price of $35.0 on 01/09/2026
- Andrew Fein from HC Wainwright & Co. set a target price of $37.0 on 01/09/2026
- Jonathan Wolleben from Citizens set a target price of $28.0 on 11/11/2025
- Jonathan Wolleben from JMP Securities set a target price of $28.0 on 09/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
